Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

ENZN 1.34 -0.01 (-0.74%)
price chart
Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock
Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Still on Royalty-Driven Autopilot
Enzon Pharmaceuticals Inc (NASDAQ:ENZN, ENZN message board) published a 10-Q report for the quarter ended Mar. 31, 2015 last week, only a few weeks after ENZN hit a 52-week high on the charts, became overbought and subsided again.
Short Interest Update of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) has seen a rise of 17,520 shares or 5.8% in the short interest. The remaining shorts are 0.7% of the total floated shares.
Three Biotech Stocks Are Tumbling - Novavax, Inc. (NASDAQ:NVAX), Enzon ...  Wall Street Observer
Micro Cap Stocks News Review - Enzon Pharmaceuticals (ENZN), Cloud Peak ...  Techsonian (press release)
Enzon Pharmaceuticals Inc Plans Special Dividend of $0.50 (ENZN)
Enzon Pharmaceuticals logo Enzon Pharmaceuticals (NASDAQ:ENZN) declared a special dividend on Tuesday, July 7th, MarketBeat.
3 Sizzling Hot Biotech Stocks - Enzon Pharmaceuticals Inc (NASDAQ:ENZN ...  Wall Street Observer
Active Trending Stocks: Enzon Pharmaceuticals, (NASDAQ:ENZN), PulteGroup ...  wsnewspublishers
Technical Coverage on Biotechnology Equities -- Achillion Pharma, CTI ...
Shares of the company traded at a PE ratio of 2.52. Enzon Pharmaceuticals Inc.'s stock has surged 20.00% in the last one month, 20.93% in the previous three months and 57.72% on YTD basis.
Company Shares of Enzon Pharmaceuticals, Inc. Drops by -8.24%
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) has dropped 8.24% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 23.81% in the last 4 weeks.
Pre-Market Buzz: Apple (AAPL), Alibaba Group (BABA), Enzon Pharmaceuticals ...
Enzon Pharmaceuticals Inc. (ENZN) is a big mover this pre-market session with its shares spiking 8% to $1.32. On June 30, 2015 the company's board of directors declared a special cash dividend of $0.50 per share of the company's common stock, payable ...
Enzon Pharmaceuticals (ENZN) Weak On High Volume Today
Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of ...
Enzon Pharmaceuticals (ENZN) Stock | Get Ready For Another Climb
Enzon Pharmaceuticals had a great week in the market last week. Unfortunately however, the stock is ... The company has been adding new prospects to its treatment repertoire and everything seems to be going well.
The Enzon Pharmaceuticals Pendulum is Poised to Swing the Other Way Again (ENZN)  SmallCap Network
Traders Alert - Enzon (ENZN), StemCells (STEM), Can (CANF), QUALCOMM (QCOM)  Investor Wired
Enzon Pharmaceuticals (ENZN) Stock | Is Now The Time To Buy?
Enzon Pharmaceuticals is a great company which develops treatments for patients who's needs are currently unmet; and investors are interested.